等待開盤 08-14 09:30:00 美东时间
-0.200
-0.25%
Keros Therapeutics has initiated dosing of the first patient in its Phase 3 RENEW trial for elritercept in adults with transfusion-dependent anemia linked to MDS, triggering a $10 million milestone payment from Takeda under their global license agreement. Elritercept, a TGF-β receptor engineered ligand trap, aims to reduce red blood cell transfusions in these patients.
07-17 12:00
今日重点评级关注:花旗:维持ProKidney Corp. - Class A Ordinary Shares"买入"评级,目标价从6美元升至9美元;Canaccord Genuity:维持e.l.f. Beauty"买入"评级,目标价从114美元升至150美元
07-10 09:55
Kura Sushi (($KRUS)) has held its Q3 earnings call. Read on for the main highli...
07-10 08:02
TD Securities analyst Andrew Charles reiterates Kura Sushi USA (NASDAQ:KRUS) with a Hold and maintains $79 price target.
07-09 20:54
Kura Sishi USA (NASDAQ:KRUS) shot up in postmarket trading on Tuesday after topping Q3 earnings expectations on revenue growth of 17.2%. CEO Hajime Uba said the quarter was a very busy one for the com...
07-09 04:28
Kura Sushi USA (NASDAQ:KRUS) raises FY2025 sales outlook from $275.00 million-$279.00 million to $281.00 million vs $278.70 million estimate.
07-09 04:09
Companies Reporting Before The Bell Companies Reporting After The Bell • Aehr T...
07-08 16:32
With U.S. stock futures trading mixed this morning on Tuesday, some of the stoc...
07-08 14:35
Kura Sushi USA (NASDAQ:KRUS) will release its quarterly earnings report on Tues...
07-08 00:01
今日重点评级关注:Benchmark:维持特斯拉(TSLA)"买入"评级,目标价从350美元升至475美元>>
06-27 08:37